A study published this week found that half of clinical trials in Europe did not have results available as required by law.

This joint initiative by Salud por Derecho, Health Action International (HAI), and Public Citizen raises serious concerns about the lack of transparency and access safeguards in the European Commissio...

This statement to the 6th meeting of the IGWG on WHO Pandemic Agreement was delivered on behalf of HAI, Salud por Derecho  and Public Citizen

Kenyans’ access to a range of health products – including HIV treatment, maternal medicine, and contraceptives – plunged in three counties last year, largely

New research from the SHARP Project has revealed a troubling drop in the availability of essential SRH supplies in rural Kenya.

Introduction Millions of people lack access to safe and effective pharmaceuticals because they are unaffordable or unavailable, particularly in ‘developing’ and ‘least-developed’ countries (DCs, LDCs)...

TRIPS flexibilities can play a key role in ensuring global and equitable access to medical countermeasures

YouTube video by Wemos

YouTube video by Wemos

The findings for country surveys looking at diabetes and UHC in 8 countries in various geographic regions and income groups.

TRIPS flexibilities can play a key role in ensuring global and equitable access to medical countermeasures

On the 24-25 November 2025, the 7th European Union (EU) and African Union (AU) Summit will take place, in Luanda (Angola). European civil society organisations working in global health have released a...

By answering some simple questions, those using AI in healthcare settings can protect patients and their rights.

Poverty porn is unethical, perpetuates negative stereotypes, and harms individuals and communities, so stop using it!

YouTube video by Dutch Global Health Alliance

The European Union has been debating the new pharmaceutical reform for years, a package of regulatory changes that updates medicines legislation. In June this year, the Council of the EU

Global leaders with advanced expertise in public health policy, research, measuring price and availability of medicines, and advocacy.